WuXi buys two Chinese CROs in clinical trial expansion
WuXi PharmaTech has expanded into Phase I-IV clinical trial services through the acquisition of two China-based CROs.
Archives for October 24, 2011
News from Novocure, YM BioSciences, and SGVI – People on the move
in-PharmaTechnologist presents its round-up of the latest appointments within the pharmaceutical industry, including news from Novocure, YM BioSciences, and SGVI.